| 常用名 | Ipivivint | CAS号 | 1481617-15-5 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Ipivivint, a first-in-class, orally active and potent CDC-like kinase (CLK) inhibitor, inhibits CLK1 (IC50=1.4 μM), CLK2 (IC50=0.002 μM) and CLK3 (IC50=0.022 μM). Ipivivint reduces Wnt pathway signaling gene expression through inhibiting CLK activity and serine and arginine rich splicing factor (SRSF) phosphorylation and disrupting spliceosome activity. Ipivivint can be used for the research of cancer[1]. 物理化学性质: CAS号:1481617-15-5 常用中文名:Ipivivint 常用英文名:Ipivivint 分子式:C26H21FN8 分子量:464.50 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |